b12 deficiency glp 1 GLP-1 weight loss drugs leave users low on key nutrients, study finds GLP-1 + NAD+ + B12:

However, by 2031, this figure is expected to surge almost 50-fold, indicating a strong market potential outside of GLP-1R drugs (Figure 1)

Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers

Our medical providers specialize in weight loss treatments, including prescription GLP-1 medications, with a focus on safety and personalized care

Leslie Cole, Director of behavioral health

DPP-4 inhibitors (DPP-4i) enhance plasma levels of GLP-1 and several other GI hormones including GIP by inhibiting their degradation

Shima Hadidchi, MD , provides attentive care and education for patients beginning their Semaglutide (GLP-1) treatment